Biovie Inc Stock Today
| BIVI Stock | USD 3.05 0.06 1.93% |
Performance5 of 100
| Odds Of DistressOver 77
|
Biovie is trading at 3.05 as of the 23rd of November 2024. This is a 1.93 percent decrease since the beginning of the trading day. The stock's open price was 3.11. Biovie has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Biovie Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of October 2023 and ending today, the 23rd of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 5th of May 2014 | Category Healthcare | Classification Health Care |
BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada. The company has 17.77 M outstanding shares of which 1.92 M shares are currently shorted by private and institutional investors with about 0.15 trading days to cover. More on Biovie Inc
Moving against Biovie Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Biovie Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Cuong MBA | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsBiovie can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Biovie's financial leverage. It provides some insight into what part of Biovie's total assets is financed by creditors.
| |||||
Biovie Inc (BIVI) is traded on NASDAQ Exchange in USA. It is located in 680 West Nye Lane, Carson City, NV, United States, 89703 and employs 14 people. Biovie is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 54.19 M. Biovie Inc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 17.77 M outstanding shares of which 1.92 M shares are currently shorted by private and institutional investors with about 0.15 trading days to cover.
Biovie Inc currently holds about 18.64 M in cash with (27.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.62.
Check Biovie Probability Of Bankruptcy
Ownership AllocationBiovie holds a total of 17.77 Million outstanding shares. Biovie Inc shows 13.69 percent of its outstanding shares held by insiders and 9.98 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Biovie Ownership Details
Biovie Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Financial Perspectives Inc | 2024-09-30 | 59.0 | |
| Albion Financial Group (utah) | 2024-06-30 | 50.0 | |
| New York State Common Retirement Fund | 2024-06-30 | 35.0 | |
| Jaffetilchin Investment Partners, Llc | 2024-09-30 | 21.0 | |
| Sanctuary Wealth Management, Llc | 2024-09-30 | 1.0 | |
| Spire Wealth Management | 2024-09-30 | 0.0 | |
| Citadel Advisors Llc | 2024-06-30 | 0.0 | |
| Millennium Management Llc | 2024-06-30 | 0.0 | |
| Good Life Advisors, Llc | 2024-09-30 | 0.0 | |
| Vanguard Group Inc | 2024-09-30 | 56.8 K | |
| Envestnet Asset Management Inc | 2024-06-30 | 53.7 K |
Biovie Historical Income Statement
Biovie Stock Against Markets
Biovie Corporate Management
| Joseph MD | Executive Officer | Profile | |
| Clarence Ahlem | Senior Operations | Profile | |
| Joanne CPA | Treasurer CFO | Profile | |
| Denise Smith | Senior Development | Profile | |
| Sarah Hoit | Chief Officer | Profile | |
| MBA MBA | CEO Pres | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biovie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biovie. If investors know Biovie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biovie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.08) | Return On Assets (0.67) | Return On Equity (2.08) |
The market value of Biovie Inc is measured differently than its book value, which is the value of Biovie that is recorded on the company's balance sheet. Investors also form their own opinion of Biovie's value that differs from its market value or its book value, called intrinsic value, which is Biovie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biovie's market value can be influenced by many factors that don't directly affect Biovie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biovie's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biovie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biovie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.